(905) 271 2709 mail@focalpointresearch.net
Focal Point
  • Home
  • About
  • Team
  • Services
    • Cosmetic Consultants
    • Natural Health Products
    • Drugs
    • Medical Devices
    • Consumer Products
    • Technology
    • FDA Consulting
    • Health Canada Consultants
    • Regulatory Affairs
    • Pharmacovigilance Services
  • Innovation
  • Articles
  • Contact
Select Page
The Beauty Industry After the Coronavirus Pandemic

The Beauty Industry After the Coronavirus Pandemic

by Jennifer P | Jun 9, 2020 | Cosmetics, Events/Company Updates

With many countries announcing or starting to implement their post COVID-19 pandemic re-opening strategies, it is important to review the plans and how the cosmetic and beauty industry will be impacted by these...
COVID-19 Impacts on Biomedical Technology Industry

COVID-19 Impacts on Biomedical Technology Industry

by Jennifer P | Jun 3, 2020 | Innovation, Medical Devices, Research/Science/Technology

We have touched on many subjects regarding the COVID-19 pandemic, such as cosmetics, sanitization products, and updates to international regulations. However, there is one topic we have yet to discuss that has experienced a great impact during this difficult time, the...
Revisions to Health Canada’s COVID-19 Hand Sanitizer and Disinfectant Interim Policies

Revisions to Health Canada’s COVID-19 Hand Sanitizer and Disinfectant Interim Policies

by Jennifer P | May 20, 2020 | Canadian Regulatory, Medical Devices

In March, Health Canada put in place an interim policy for their regulations for hand sanitizers and disinfectant products. This was in response to the high supply and demand for these types of products due to the COVID-19 pandemic, which caused a 735% increase in...
Health Canada Guidance Document on Interim Expedited Hand Sanitizer Approval Process

Health Canada Guidance Document on Interim Expedited Hand Sanitizer Approval Process

by Jennifer P | Apr 16, 2020 | Canadian Regulatory, Natural Health Products

Health Canada has released a guide document pertaining to the temporary expedited process for the production and distribution of hand sanitizers in Canada. The document highlights acceptable quality grades and medicinal ingredient concentrations, formulation...
A Summary of International Efforts in Minimizing the Spread of COVID-19

A Summary of International Efforts in Minimizing the Spread of COVID-19

by Jennifer P | Apr 3, 2020 | Canadian Regulatory, Innovation, Medical Devices, Research/Science/Technology, U.S. Regulatory

Recently, information has been provided regarding updates that Health Canada and the U.S. FDA have done in order to aid in the battle against COVID-19. However, other countries have also taken drastic measures to assist with reducing the spread of COVID-19. The...
« Older Entries
Next Entries »

Recent Posts

  • California Assembly Bill No. 818
  • New Legislation for North Carolina
  • Amendment to the Quebec Charter of the French Language
  • Potential Presence of Toxic Substances in Cosmetics
  • FDA OTC MONOGRAPH DRUG USER FEE RATES FOR FISCAL YEAR 2022

Recent Comments

    Archives

    • April 2022
    • March 2022
    • October 2021
    • July 2021
    • April 2021
    • March 2021
    • February 2021
    • January 2021
    • November 2020
    • October 2020
    • August 2020
    • July 2020
    • June 2020
    • May 2020
    • April 2020
    • March 2020
    • February 2020
    • January 2020
    • December 2019
    • November 2019
    • October 2019
    • September 2019
    • August 2019
    • July 2019
    • May 2019
    • April 2019
    • March 2019
    • February 2019
    • January 2019
    • December 2018
    • November 2018
    • October 2018
    • September 2018
    • August 2018
    • July 2018
    • June 2018
    • May 2018
    • April 2018
    • March 2018
    • February 2018
    • January 2018

    Categories

    • Canadian Quality Assurance
    • Canadian Regulatory
    • Cosmetics
    • European Regulatory
    • Events/Company Updates
    • Importation of NHPs
    • Innovation
    • Medical Devices
    • Natural Health Products
    • OTC Drugs
    • Our View
    • Research/Science/Technology
    • U.S. Regulatory
    • Uncategorized

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    Copyright © 2021 Focal Point Research Inc.
    Privacy Policy | Terms of Use
    Website Design and Development by PLAY
    ×

    Delsie Braganza

    Delsie joined the Focal Point Research team in 2011 and has been an invaluable asset for our clients. With her strong regulatory and quality assurance background, she is able to audit facilities, set up and maintain GMP compliant facilities, develop strong quality management systems, and co-ordinate successful Health Canada inspections. In addition to this, Delsie oversees all submissions made to Health Canada and the US FDA.

    Delsie obtained an Honours Bachelor of Science (Hons. B. Sc.) in Pharmaceutical Chemistry from the University of Toronto, Post-Graduate Certificate in Pharmaceutical Regulatory Affairs and Quality Operations (RAQ) from Seneca College and Regulatory Affairs Certification (RAC) from the Regulatory Affairs Professional Society (RAPS). When she’s not learning something new, Delsie loves spending time with family, going on road trips or long walks, and swimming.

     

    ×

    Jennifer Porter, BA Psychology, MBA – President & CEO

    Jennifer has been bringing new products to market for over 10 years. Her career with Focal Point Research has a foundation based on service excellence, leadership, and a passion for both the cosmetic and health products industries.

    With the successful development of hundreds of new products, Jennifer was the obvious choice to lead Focal Point Research into the future as the successor to company founder, Rob Fichtner.

    Jennifer balances her career by honouring her wanderlust and adopting rescue dogs along the way.

    ×

    Robert Fichtner

    Since co-founding Focal Point over 20 years ago, Rob has led our Regulatory and Scientific practice. A chemist by training, his experience includes Cosmetics, Drugs, Medical Devices, Consumer Products and Natural Health Products (Dietary Supplements). Rob has participated in the launch of thousands of products including their formulation, manufacturing and regulatory submissions for approval. His wealth of experience spans almost 40 years in innovation.
    Rob has been involved in all aspects of innovation and new product development. He shares some of his insights in his new video series “Lectures in Innovation”. You can view the first video here.
    When not supporting innovators, Rob spends his time becoming a better sailor and guitar player.